<乌鸦传媒>Kidney Week Roundup: Cell Therapy Cuts Immunosuppressive Drug Use Post-Transplant Plus: bardoxolone methyl for diabetic kidney disease and spironolactone in hemodialysis patients Nov 07, 2023
<乌鸦传媒>Another Xenotransplant Death; Many Unaware of HF Diagnosis; Full-Body TAVR Protector Recent developments of interest in cardiovascular medicine Nov 07, 2023
<乌鸦传媒>Heart Injuries Suggest Reconsideration of Holding BP Meds for Surgery Pause on ACE inhibitors, ARBs yields more acute hypertension with no prevention of hypotension Nov 06, 2023
<乌鸦传媒>Rampant Stent Overuse; Hot Tub Heart Risks Revisited; Cardiologist Runs for Office Recent developments of interest in cardiovascular medicine Oct 31, 2023
<乌鸦传媒>EP Study During TAVR Offers Better Prediction of Late Conduction Disturbances Interventional cardiologists trained to handle His bundle recordings at one center Oct 27, 2023
<乌鸦传媒>Tricuspid Valve Replacement Safe, Effective in Pivotal Trial Outcome data still awaited after positive interim results Oct 27, 2023
<乌鸦传媒>Small Aortic Annuli Not Inherently More Amenable to TAVR TAVR, SAVR result in similar outcomes in female-dominated VIVA randomized trial Oct 26, 2023
<乌鸦传媒>Tricuspid Clip Might Work for More Patients Than Thought Study shows better-than-expected benefit for expanded criteria cohort Oct 26, 2023
<乌鸦传媒>Early Experience Keeps Tendyne TMVR on Track for MR and Severe MAC Will preliminary results be confirmed by SUMMIT trial to come? Oct 25, 2023
<乌鸦传媒>Low-Risk TAVR Converging or Diverging With Surgical Outcomes, Depending on the Valve Intermediate-term reports from PARTNER 3 and Evolut Low Risk trials Oct 24, 2023
<乌鸦传媒>Extravascular ICD OK'd; Win for Million Hearts; SGLT2i Struggles at EF>60% Recent developments of interest in cardiovascular medicine Oct 24, 2023
<乌鸦传媒>CT for Endovascular Tx; Aortic Dissection Patch; Rape Trial for Denver Cardiologist Recent developments of interest in cardiovascular medicine Oct 17, 2023
<乌鸦传媒>Novel Nerve Ablation Procedure Explored for HFpEF Splanchnic nerve ablation for volume management passes a feasibility hurdle Oct 11, 2023
<乌鸦传媒>Copper-Boosting Agent Promising for Low Ejection Fraction Heart Failure Early-phase study analysis suggests potential for remodeling Oct 10, 2023
<乌鸦传媒>Modest Risks Come With Moving Fast on HF Drugs After Acute Event STRONG-HF analysis details the impact Oct 10, 2023
<乌鸦传媒>Vagus Nerve Stimulation in Limbo for HFrEF Autonomic regulation therapy trial showed signal for benefit in terminated pivotal trial Oct 09, 2023
<乌鸦传媒>Biomarker-Based CardioMEMS Candidates Still Benefit GUIDE-HF trial analysis distinguishes "strata" with different levels of risk Oct 09, 2023
<乌鸦传媒>FDA Turns Down ATTR Cardiomyopathy Drug Decision cites insufficient evidence of clinical meaningfulness Oct 09, 2023
<乌鸦传媒>Weight-Loss Drug Benefit Spans HFpEF, HFmrEF STEP-HFpEF trial results come out consistent across ejection fraction Oct 08, 2023
<乌鸦传媒>Fast-Acting Spray for PSVT; Undiscounted Entresto's Value; CTCA-Aided Angiography Recent developments of interest in cardiovascular medicine Oct 03, 2023
<乌鸦传媒>Repeat Tests for Inflammation Aid Prognosis After Acute Heart Failure Mortality predicted by cumulative hsCRP levels over time Oct 02, 2023
<乌鸦传媒>New Two-Tier System to Weed Out Some Pediatric Heart Surgery Centers Low-volume congenital and pediatric heart programs may be cut in national reorganization Sep 29, 2023
<乌鸦传媒>New Cardiology Board to Come; 2nd Pig-Heart Xenotransplant; Uric Acid as Stroke Tx? Recent developments of interest in cardiovascular medicine Sep 26, 2023
<乌鸦传媒>Reassuring Registry Data on Going Into TAVR Sans Symptoms Would intervention beat watchful waiting for asymptomatic patients with severe aortic stenosis? Sep 20, 2023
<乌鸦传媒>Link Between Psoriasis, Heart Disease Tracks to Coronary Microvascular Dysfunction Lower coronary flow reserve associated with severity, duration of psoriasis Sep 20, 2023
<乌鸦传媒>Should Surgical AVR for Aortic Regurgitation Happen Earlier in Young Adults? Waiting to meet standard criteria less likely to lead to LV normalization Sep 19, 2023
<乌鸦传媒>FXI Inhibitor Cuts Bleeds in Afib; COAPT Extends to Real World; AI Stroke Triage Recent developments of interest in cardiovascular medicine Sep 19, 2023
<乌鸦传媒>No Avoiding Mitral Valve Implant Obstruction With Preemptive Ablation LVOT obstruction remains thorn in the side of TMVI in small case series Sep 15, 2023
<乌鸦传媒>FDA Panel Reluctantly Backs Patisiran for ATTR Cardiomyopathy Clinical meaningfulness is a different question, however Sep 13, 2023
<乌鸦传媒>Upfront Ezetimibe in ACS; New Watchman LAA Occluder OK'd; Low-Cost FH Genotyping Recent developments of interest in cardiovascular medicine Sep 12, 2023
<乌鸦传媒>Beneficial Produce Scripts; Aortic Dissection Deaths Up; New Opioid & Cardiac Arrest Recent developments of interest in cardiovascular medicine Sep 05, 2023
<乌鸦传媒>Novel Amyloid Drug Improves Mid-Term Outcomes in ATTR Cardiomyopathy Pivotal trial "suggests the tantalizing possibility of genuine clinical improvement" Aug 29, 2023
<乌鸦传媒>OCT Angioplasty Win; Congenital Defect Found in Bronny James; Gene Tx for Angina Recent developments of interest in cardiovascular medicine Aug 29, 2023
<乌鸦传媒>'Big Win' for Anti-Obesity Medication in Heart Failure Semaglutide led to meaningful reductions in symptoms, weight in patients with obesity and HFpEF Aug 29, 2023 video
<乌鸦传媒>Immune Suppressant Stumbles for Acute Myocarditis in Early Data Phase II trial might not end the story for anti-inflammatory approach, though Aug 28, 2023
<乌鸦传媒>Afib Ablation Exceeds Expectations in Sickest Heart Failure Patients Death and surgeries delayed in end-stage heart failure Aug 28, 2023
<乌鸦传媒>CRT-D Upgrade Suits Patients With Pacing-Related Heart Failure BUDAPEST-CRT Upgrade is the first major trial on upgrade strategy Aug 27, 2023
<乌鸦传媒>Iron Infusions Narrowly Miss the Mark for Clinical Benefit in Heart Failure Hard endpoints do not favor IV ferric carboxymaltose in well-powered HEART-FID Aug 26, 2023
<乌鸦传媒>SGLT2 Inhibitors, Rapid Titration, IV Iron Get a Boost in New European HF Guideline Other recommendations also released for endocarditis, cardiomyopathies, ACS, and more Aug 25, 2023
<乌鸦传媒>Wegovy Reduces Heavy Symptom Burden of Obesity-Related Heart Failure Heart failure with preserved ejection fraction and obesity becoming more common Aug 25, 2023
